These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1386260)

  • 1. Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders.
    Kornberg A; Francis CW; Marder VJ
    Blood; 1992 Aug; 80(3):709-17. PubMed ID: 1386260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers.
    Francis CW; Doughney K; Brenner B; Klingbiel K; Marder VJ
    Circulation; 1989 Mar; 79(3):666-73. PubMed ID: 2465100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
    Connaghan DG; Francis CW; Lane DA; Marder VJ
    Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
    J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
    Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique.
    Francis CW; Marder VJ; Martin SE
    Blood; 1979 Dec; 54(6):1282-95. PubMed ID: 508938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Francis CW; Connaghan DG; Marder VJ
    Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
    Petrova IuI; Savchuk OM; Kalashnyk OM; Platonova TM; Skok MV; Cederholm-Williams S
    Ukr Biokhim Zh (1999); 2004; 76(2):64-8. PubMed ID: 15915713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
    Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
    Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin subunits in venous and arterial thromboembolism.
    Gaffney PJ; Brasher M; Lord K; Strachan CJ; Wilkinson AR; Kakkar VV; Scully MF
    Cardiovasc Res; 1976 Jul; 10(4):421-6. PubMed ID: 133759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.
    Gaffney PJ; Lane DA; Brasher M
    Clin Sci Mol Med; 1975 Aug; 49(2):149-56. PubMed ID: 125178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase.
    Holvoet P; Laroche Y; Lijnen HR; Van Cauwenberge R; Demarsin E; Brouwers E; Matthyssens G; Collen D
    J Biol Chem; 1991 Oct; 266(29):19717-24. PubMed ID: 1918077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.